Ken Griffin’s Verrica Pharmaceuticals VRCA Stock Holding History

Ken Griffin’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,866	Closed	-$36.4K	–	14238
2025 Q2	$36.4K	Buy	+6,866	New	+$36.9K	﹤0.01%	11913
2025 Q1	–	Sell	-2,029	Closed	-$14.2K	–	15658
2024 Q4	$14.2K	Buy	+2,029	New	+$22.3K	﹤0.01%	13412
2024 Q3	–	Sell	-2,278	Closed	-$103K	–	15341
2024 Q2	$166K	Buy	+2,278	New	+$175K	﹤0.01%	10192
2023 Q4	–	Sell	-1,758	Closed	-$72.2K	–	15335
2023 Q3	$68.3K	Sell	1,758 -7,075	-80%	-$360K	﹤0.01%	11353
2023 Q2	$510K	Buy	8,833 +5,336	+153%	+$324K	﹤0.01%	7903
2023 Q1	$227K	Sell	3,497 -3,748	-52%	-$227K	﹤0.01%	9952
2022 Q4	$199K	Sell	7,245 -100	-1%	-$2.67K	﹤0.01%	10148
2022 Q3	$215K	Buy	7,345 +3,194	+77%	+$109K	﹤0.01%	10273
2022 Q2	$80K	Buy	4,151 +1,187	+40%	+$59.7K	﹤0.01%	11597
2022 Q1	$240K	Buy	+2,964	New	+$244K	﹤0.01%	11107

Other funds holding VRCA

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Ken Griffin's VRCA Position: Q3 2025 in Review

Ken Griffin sold out of Verrica Pharmaceuticals (VRCA) in Q3 2025, closing a stake of 6,866 shares — an estimated $36.4K sold.

Ken Griffin first reported a position in VRCA in Q1 2022 and held it in 10 quarters. The position peaked at $510K in Q2 2023. 34 funds tracked by Wall St. Rank hold VRCA as of Q3 2025.

Ken Griffin reported no remaining Verrica Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Ken Griffin sold 6,866 Verrica Pharmaceuticals shares in Q3 2025, an estimated $36.4K.
Ken Griffin first reported a position in Verrica Pharmaceuticals in Q1 2022 and held it in 10 quarters.
Ken Griffin's Verrica Pharmaceuticals position peaked at $510K in Q2 2023.
34 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.